Blood Glucose Monitoring System gives results in 10 sec.
Press Release Summary:
Designed for rigors of use within long-term care (LTC) facilities, Assure® 4 Blood Glucose Monitoring System requires 1.5 µL sample size, and has 50 count test memory. FDA approved unit features contour design and Guide-Me Curve(TM) test strip that guides the finger to sample application tip for testing.
Original Press Release:
ARKRAY USA Launches Assure® 4 Blood Glucose Monitoring System
New intuitive, easy-to-use blood glucose system designed specifically for Long-Term Care
MINNEAPOLIS, June 18 - ARKRAY USA, Inc. announced today that it has started to sell its Assure® 4 Blood Glucose Monitoring System to the Long Term Care (LTC) market. ARKRAY USA, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market this system earlier in the year.
Assure® 4 is specifically designed for the rigours of use within long-term care (LTC) facilities. This intuitive, easy-to-use system gives results in 10 seconds, requires a 1.5 microliter sample size, and has a 50-count test memory. The contour design makes the meter easy to hold. The Guide-Me Curve(TM) Test Strip guides the finger to the sample application tip for easy testing.
"Our expertise has always been in LTC and we are very excited to launch the Assure® 4 Blood Glucose Monitoring System into our core market," said Tawni Sigelmier, Director of Corporate Accounts for ARKRAY USA, Inc. "This system is a significant extension of our Assure® 3 Blood Glucose Monitoring System. The enhancements are based on feedback from the large community of healthcare professionals who currently use Assure® 3. By adding this product to our LTC portfolio, we are able to give LTC professionals the option of an easy-to-use, intuitive meter in Assure® 4 or a full-featured system in Assure Pro."
The Assure® 4 Blood Glucose Monitoring System is now available to the LTC market.
About ARKRAY USA
ARKRAY USA, Inc. (http://www.arkrayusa.com/) is a leading healthcare company specializing in diagnostic products and medical devices at the point of care. ARKRAY develops, manufactures, and markets innovative diagnostic products and related medical devices used in managing chronic diseases such as diabetes, screening for acute conditions utilizing blood and urine diagnostics, and enhancing healthcare worker safety. The company's primary products include a broad line of blood glucose monitoring systems, safety lancets and lancing devices, as well as urine testing equipment and supplies. ARKRAY's focus is to improve today's technology to develop products that are even more convenient and safe.
Source: ARKRAY USA, Inc.
CONTACT:
Michelle Dumonceaux,
Senior Marketing Manager of ARKRAY USA, Inc.,
+1-952-646-3225,
info@arkrayusa.com
Web site: http://www.arkrayusa.com/
